Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05162_nanopub.RAgTQDa1W0nRUnSmntblgokg6e3FeVEea9-ohz2L5GTc8#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05162 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05162 label "GSK716155 [drugbank:DB05162]" assertion.
- drugbank:DB05162 seeAlso DB05162 assertion.
- drugbank:DB05162 description "GSK716155 (formerly Albugon), a novel long-acting form of glucagon-like peptide-1 (GLP-1), is in clinical trials for the treatment of Type 2 diabetes. It was created using Human Genome Sciences' proprietary albuminfusion technology, which involves fusing the gene that expresses human albumin to the gene that expresses a therapeutically active protein." assertion.
- drugbank:DB05162 identifier "drugbank:DB05162" assertion.
- drugbank:DB05162 title "GSK716155" assertion.
- drugbank:DB05162 drugbank_vocabulary:x-cas cas:782500-75-8 assertion.
- drugbank:DB05162 drugbank_vocabulary:drugbank-id "DB05162" assertion.
- drugbank:DB05162 bio2rdf_vocabulary:x-identifiers.org DB05162 assertion.
- drugbank:DB05162 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05162" assertion.
- drugbank:DB05162 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05162 bio2rdf_vocabulary:identifier "DB05162" assertion.